Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis [NA]

View source ↗

Summary

This clinical trial update notes the potential relevance of modifying RANKL signaling during folliculogenesis in women with infertility, with the trial currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Peter Humaidan | Conditions: Female Infertility, NF-κB Ligand | NA | Status: RECRUITING